Dong Cheng Jiang
Corporate Officer/Principal at Sunho Biologics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Liu Song Yin | M | 37 |
SunHo (China) Biopharmaceutical Co. Ltd.
Sunho Biologics, Inc.
 Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 4 years |
| Feng Zhang | M | 51 |
SunHo (China) Biopharmaceutical Co. Ltd.
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 3 years |
| Xiao Ling Jiang | F | 42 |
SunHo (China) Biopharmaceutical Co. Ltd.
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 4 years |
| Chun Qin Xu | F | 45 |
SunHo (China) Biopharmaceutical Co. Ltd.
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 3 years |
| Lu Wen Shi | M | 60 |
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 1 years |
| Lan Feng | F | 45 |
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 1 years |
| Heung Wing Chan | M | 50 |
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 1 years |
| Chun Hong Hao | M | 60 |
Inner Mongolia University
| 20 years |
| Hoi Ting Wong | F | 36 |
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 1 years |
| Rong Kui Fan | M | 32 |
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cun Ren Ceng | M | 55 |
Chongqing University
| 1 years |
| Bing Qin | M | 52 |
Chongqing University
| 1 years |
| Yue Min Ni | F | 58 |
Chongqing University
| 2 years |
| Wei Qin | M | 62 |
Chongqing University
| 2 years |
| Jian Hua Liu | M | 58 |
Chongqing University
| 2 years |
| Xiao Hong Zhou | M | 57 |
Chongqing University
| 2 years |
| Wenguang Sun | M | 57 |
Chongqing University
| 2 years |
| Xiao Hu Dong | M | 44 |
Inner Mongolia University
| 4 years |
| Peng Fei Ding | M | 41 |
Inner Mongolia University
| 4 years |
| Zhangcai He | M | 50 |
Chongqing University
| 4 years |
| Bin Zheng | M | 54 |
Chongqing University
| 1 years |
| Ze Zheng Liu | M | 43 |
Inner Mongolia University
| 4 years |
| Ling Jie Wang | F | 41 |
Inner Mongolia University
| 4 years |
| Ruibin Xu | M | 53 |
Inner Mongolia University
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 24 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dong Cheng Jiang
- Personal Network
